Anonymous
(ID: Ol2DSI9b)
6/20/2025, 9:32:31 AM
No.508069142
[Report]
>>508070016
>>508070194
>>508070791
>>508070818
>>508070993
>>508071198
>>508071759
>>508073693
>>508073765
>>508073783
>>508073836
>>508074316
>>508075641
>>508076431
>>508076532
>>508078223
>>508079930
>>508080288
>>508080684
>>508080807
>>508081370
>>508081403
>>508082637
>>508082980
>>508083106
>>508084359
>>508085316
>>508085556
>>508086142
>>508086904
>>508087918
People who received genetic mRNA/vector "vaccines" during 2020/2022 covid pandemic may require long-term or lifelong medications to decrease a bit the risk of a sudden cardiac arrest in the future.
The alert was issued by a team of leading American researchers from Virginia Commonwealth University (VCU) Pauley Heart Center.
Led by Dr. Michele Marchetta, the researchers sought to investigate the long-term risk from recurrent usymptomatic pericarditis following Covid mRNA injections.
>All patients tested negative for acute SARS-CoV-2 infection. The median age of the group was 56 years, ranging from 17 to 82. 6 had received Pfizer and 2 had received Moderna.
>All patients developed chest pain within a median of 14 days post-vaccination. Pericardial effusion was seen in 6 patients; 1 progressed to tamponade.
>This report revealed troubling evidence of patients who experience chronic, debilitating, and relapsing symptoms caused by mRNA vaccines.
>Most of the heart damage might occur without any symptoms.
>Pericarditis following SARS-CoV-2 vaccination can evolve into a recurrent, difficult-to-manage inflammatory condition. Effective treatment may require IL-1 blockade to disrupt the autoinflammatory cycle
>Clinicians should remain alert to persistent post-vaccine heart issues, the researchers warn.
https://www.internationaljournalofcardiology.com/article/S0167-5273(25)00559-5/abstract
The alert was issued by a team of leading American researchers from Virginia Commonwealth University (VCU) Pauley Heart Center.
Led by Dr. Michele Marchetta, the researchers sought to investigate the long-term risk from recurrent usymptomatic pericarditis following Covid mRNA injections.
>All patients tested negative for acute SARS-CoV-2 infection. The median age of the group was 56 years, ranging from 17 to 82. 6 had received Pfizer and 2 had received Moderna.
>All patients developed chest pain within a median of 14 days post-vaccination. Pericardial effusion was seen in 6 patients; 1 progressed to tamponade.
>This report revealed troubling evidence of patients who experience chronic, debilitating, and relapsing symptoms caused by mRNA vaccines.
>Most of the heart damage might occur without any symptoms.
>Pericarditis following SARS-CoV-2 vaccination can evolve into a recurrent, difficult-to-manage inflammatory condition. Effective treatment may require IL-1 blockade to disrupt the autoinflammatory cycle
>Clinicians should remain alert to persistent post-vaccine heart issues, the researchers warn.
https://www.internationaljournalofcardiology.com/article/S0167-5273(25)00559-5/abstract